You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TPST Award Disclosure
Smith Nancy Freda · SEC Form 4 · Filed Oct 2, 2026
Award
Calculated transaction value
$0
Smith Nancy Freda Director
TPST
Tempest Therapeutics
TPST
Transaction date
Sep 22, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 10 days later
TPST daily price context
Close on/before transaction
$1
Sep 22, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 25,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-106400
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tempest Therapeutics, Inc. TPST Current | Award | Sep 22, 2026 | $0 |